Skip to main content

Table 2 Logistic regression analysis showing associations between TB treatment outcomes and potential predictors, DTGH, 2008–2016

From: Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: nine-years retrospective study

Variables

TB treatment outcomea

cOR (95% CI)

P value

aOR (95% CI)

P value

Unsuccessful n (%)

Successful n (%)

Sex

Male

45 (5.7)

344 (94.3)

1

 

1

 

Female

29 (8.1)

328 (91.9)

1.5(0.92.4)

0.12

1.5(0.9–2.5)

0.10

Age group (in years)

0–14

8 (11.6)

61(88.4)

1

 

1

 

15–24

17 (7.2)

220(92.)

1.7(0.7–4)

0.24

1.8(0.73–4.46)

0.20

25–34

11 (6.4)

160(93.)

1.9(0.7–5)

0.19

2(0.77–5.4)

0.15

35–44

18 (16.5)

91 (83.5)

0.66(0.27–1.6)

0.37

0.73(0.29–1.8)

0.50

45–54

7 (9.2)

60 (90.8)

1.12(0.38–3.3)

0.8

1.18(0.4–3.5)

0.76

55–64

6 (8.3)

36 (91.7)

0.78(0.25–2.45)

0.68

0.8(0.25–2.5)

0.70

≥ 65

7 (13.7)

44 (86.3)

0.8(0.28–2.4)

0.72

0.86(0.3–2.6)

0.78

Type of TB

PTB+

18 (9.5)

171(90.5)

1

 

1

 

PTB-

29 (10.5)

247(89.5)

0.89(0.48–1.66)

0.70

1.04(0.5–2)

0.89

EPTB

27 (9.6)

254(90.4)

0.99(0.5–1.8)

0.98

1.04(0.5–2)

0.89

TB registration status

New

62 (10.1)

550(89.9)

1

 

1

 

Relapse

4 (8.2)

45 (91.8)

1.3(0.44–3.6)

0.66

1.48(0.5–4.4)

0.47

Treatment after Failure

1(5.9)

16 (94.1)

1.8(0.23–31.8)

0.57

1.6(0.2–12.7)

0.65

Transfer in

6 (9.7)

56 (90.3)

1.05(0.44–2.5)

0.9

0.93(0.37–3)

0.87

Other

1 (16.7)

5 (83.3)

0.56(0.06–4.9)

0.6

0.37(0.04–3.3)

0.37

HIV status

Positive

21 (11.9)

155(88.1)

1

 

1

 

Negative

50 (9.2)

494(90.8)

1.33(0.78–2.3)

0.30

1.37(0.76–2.4)

0.23

Unknon

3 (11.5)

23 (88.5)

1.03(0.28–3.76)

0.95

1.13(0.3–4.2)

0.5

  1. aNB: the calculation excluded transferred out (n = 219) and treatment outcome unknown (20) cases